S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A83.0 KBSatsuma Pharmaceuticals, Inc.Jun 12, 6:57 PM ET·0001567619-23-006340
- SC 13D/A83.0 KBSatsuma Pharmaceuticals, Inc.Jun 12, 5:00 PM ET·0001104659-23-070413
- SC 13D/A89.5 KBSatsuma Pharmaceuticals, Inc.Jun 8, 9:17 AM ET·0001193125-23-163095
- 8-K337.8 KBSatsuma Pharmaceuticals, Inc.Jun 8, 9:13 AM ET·0001193125-23-163082
- 8-K183.1 KBSatsuma Pharmaceuticals, Inc.May 18, 4:20 PM ET·0001193125-23-148162
- 10-Q7.4 MBSatsuma Pharmaceuticals, Inc.May 11, 4:05 PM ET·0000950170-23-021208
- 8-K147.1 KBSatsuma Pharmaceuticals, Inc.May 3, 4:11 PM ET·0001193125-23-134402
- SC 13D/A129.1 KBSatsuma Pharmaceuticals, Inc.May 2, 5:26 PM ET·0001072613-23-000316
- 10-K/A3.4 MBSatsuma Pharmaceuticals, Inc.Apr 28, 4:08 PM ET·0000950170-23-015782
- SC 13D/A101.5 KBSatsuma Pharmaceuticals, Inc.Apr 18, 4:30 PM ET·0001104659-23-046734
Insiders
10- ALBRECHT DETLEFChief Medical Officer
- BONDERMAN DAVID10% Owner
- Commodore Capital LP10% Owner
- COULTER JAMES G10% Owner
- Hadley Harbor Master Investors (Cayman) II L.P.10% Owner
- Harsch MutyaDirector
- KING THOMAS BRAXTONDirector
- Kolchinsky PeterDirector, 10% Owner
- Kollins John ADirector, President and CEO
- Leonard Braden Michael10% Owner
Tickers
No tickers on record
Addresses
business
4819 EMPEROR BOULEVARD SUITE 340
DURHAM, NC, 27703
mailing
4819 EMPEROR BOULEVARD SUITE 340
DURHAM, NC, 27703